October 2020
Numinus Legally Culitvates Magic Mushrooms in Canada
This is the first time a Canadian company has legally cultivated and harvested psychedelic mushrooms since the 1970s.
Timeline of Psychedelic Corporate Milestones
May 2020
CaaMTech Partners With NIH to Study Synthetic Tryptamines
This collaboration will study a full spectrum of pharmacological effects of several synthetic tryptamine compounds.
April 2020
MindMed and Liechti Lab Announce LSD “Off-Switch” Technology
This technology may help ease some of the concerns surrounding psychedelic therapy.
December 31, 2019
COMPASS Pathways Awarded Patent for Psilocybin Formulation COMP360
The scope and validity of the patent will depend on how x-ray diffraction data is interpreted.
December 2019
Silo Wellness Introduces First Magic Mushroom Nasal Spray
Nasal spray formulations like this could offer precision dosing of a spectrum of psychedelic mushroom compounds to consumers.
October 2018
Atai Life Sciences Raises $25 Million
German entrepreneur and investor Christian Angermayer creates Atai Life Sciences and raises $25 million to study the therapeutic effects of psychedelic drugs on depression and other mental illnesses.